Weiwei Cui

671 total citations · 1 hit paper
13 papers, 351 citations indexed

About

Weiwei Cui is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weiwei Cui has authored 13 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weiwei Cui's work include Epigenetics and DNA Methylation (4 papers), Ferroptosis and cancer prognosis (4 papers) and Pregnancy and preeclampsia studies (2 papers). Weiwei Cui is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Ferroptosis and cancer prognosis (4 papers) and Pregnancy and preeclampsia studies (2 papers). Weiwei Cui collaborates with scholars based in China and United States. Weiwei Cui's co-authors include Bo Chu, Wei Gu, Dong Liu, Bin Huang, Xiaoju Zhang, Yudan Zhang, Lutao Du, Yinghong Yang, Li Yang and Chunhui Liang and has published in prestigious journals such as Nature Communications, Trends in Cell Biology and Cell Death and Differentiation.

In The Last Decade

Weiwei Cui

13 papers receiving 348 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth

2023 107 citations Dong Liu, Chunhui Liang et al. Advanced Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiwei Cui China	8	227	176	156	40	30	13	351
Leonie Zeitler Germany	6	223 1.0×	115 0.7×	139 0.9×	131 3.3×	53 1.8×	6	393
Jong Woo Kim South Korea	9	168 0.7×	91 0.5×	78 0.5×	44 1.1×	15 0.5×	17	323
Feng Dong China	10	281 1.2×	118 0.7×	204 1.3×	40 1.0×	39 1.3×	18	439
Xiaolu Cui China	11	377 1.7×	117 0.7×	210 1.3×	40 1.0×	82 2.7×	16	512
Fuyan Xu China	7	241 1.1×	87 0.5×	101 0.6×	23 0.6×	50 1.7×	12	364
Chantal Vidal United States	5	226 1.0×	54 0.3×	124 0.8×	13 0.3×	42 1.4×	10	323
Chao‐Yuan Chang Taiwan	11	137 0.6×	61 0.3×	78 0.5×	64 1.6×	62 2.1×	26	279
Svenja Lorenz Germany	3	126 0.6×	118 0.7×	88 0.6×	46 1.1×	19 0.6×	3	217
Tomomi Hashidate‐Yoshida Japan	9	254 1.1×	51 0.3×	52 0.3×	64 1.6×	31 1.0×	19	447

Countries citing papers authored by Weiwei Cui

Since Specialization

Citations

This map shows the geographic impact of Weiwei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Cui more than expected).

Fields of papers citing papers by Weiwei Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Cui. The network helps show where Weiwei Cui may publish in the future.

Co-authorship network of co-authors of Weiwei Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Cui. A scholar is included among the top collaborators of Weiwei Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Cui. Weiwei Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Yang, Min, Weiwei Cui, Xiaoting Lv, et al.. (2025). S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism. Nature Communications. 16(1). 509–509. 12 indexed citations

2.

Li, Xue, et al.. (2024). Serum copeptin in women with gestational diabetes mellitus: A meta-analysis. Biomolecules and Biomedicine. 24(4). 753–763. 1 indexed citations

3.

Cui, Weiwei, et al.. (2024). Gut microbial metabolism in ferroptosis and colorectal cancer. Trends in Cell Biology. 35(4). 341–351. 11 indexed citations

4.

Liu, Dong, Chunhui Liang, Bin Huang, et al.. (2023). Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth. Advanced Science. 10(6). e2204006–e2204006. 107 indexed citations breakdown →

5.

Cui, Weiwei, Qian Zhang, Qing Zhao, et al.. (2023). Excessive Lipid Peroxidation in Uterine Epithelium Causes Implantation Failure and Pregnancy Loss. Advanced Science. 11(4). e2302887–e2302887. 16 indexed citations

6.

Cui, Weiwei, et al.. (2022). Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription. Molecular Cancer Research. 21(2). 115–126. 4 indexed citations

7.

Cui, Weiwei, Ruihong Zhang, Lanlan Liu, et al.. (2022). Sohlh2 Inhibits the Malignant Progression of Renal Cell Carcinoma by Upregulating Klotho via DNMT3a. Frontiers in Oncology. 11. 769493–769493. 2 indexed citations

8.

Cui, Weiwei, Dong Liu, Wei Gu, & Bo Chu. (2021). Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis. Cell Death and Differentiation. 28(8). 2536–2551. 151 indexed citations

9.

Cui, Weiwei, Ruihong Zhang, Na Zhao, et al.. (2021). SOHLH2 Suppresses Angiogenesis by Downregulating HIF1α Expression in Breast Cancer. Molecular Cancer Research. 19(9). 1498–1509. 12 indexed citations

10.

Li, Xue, et al.. (2021). Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells. Journal of Pharmacy and Pharmacology. 73(4). 545–552. 3 indexed citations

11.

Zhang, Xiaoli, Ruihua Liu, Na Zhao, et al.. (2019). Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt/β‐catenin signaling pathway. Molecular Carcinogenesis. 58(6). 1008–1018. 14 indexed citations

12.

Zhang, Xiaoli, Xinyu Liu, Weiwei Cui, et al.. (2019). Sohlh2 alleviates malignancy of EOC cells under hypoxia via inhibiting the HIF1α/CA9 signaling pathway. Biological Chemistry. 401(2). 263–271. 5 indexed citations

13.

Liu, Xinyu, Qing Gao, Na Zhao, et al.. (2017). Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β‐catenin signaling. Molecular Carcinogenesis. 57(4). 494–502. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact